Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer.

Abstract

BACKGROUND:

Podoplanin (PDPN) is a transmembrane glycoprotein that mediates tumor cell-induced platelets aggregation in different cancer types. Emerging data indicate that PDPN is a marker for poor prognosis of human oral squamous cell carcinoma (OSCC). However, the functional impacts of PDPN on cancer formation and disease progression of OSCC remain to be elucidated.

METHODS:

The sublines of the OECM-1 oral cancer cells with PDPN knockdown or overexpression were established. The cellular characteristics and the ability to induce platelet aggregation of these cells lines were analyzed. An ectopic xenograft animal model by inoculating cancer cells into the anterior neck region of nude mice was established to investigate the functional impact of PDPN on disease progression and cancer-associated thrombosis of OSCC.

RESULTS:

PDPN promoted OSCC cell migration and invasion, but had no effect on cell proliferation in vitro and tumor growth in vivo. Co-incubation of PDPN-positive (PDPN+) OSCC cells with platelets induced platelet activation and aggregation. The mice bearing PDPN+ tumor had a decrease in overall survival despite that there was no gross appearance of distant metastasis. A speckled immunofluorescence staining pattern of platelet marker mCD41 was defined in the PDPN+ tumor sections and the intensity was greater than in the PDPN-low or negative tumor sections. Co-immunofluorescence staining of the tumor sections with mCD41 and the endothelial cell marker mCD31 further demonstrated that platelet aggregates were located in the lumen of blood vessel and were also distributed intratumorally in the mice bearing PDPN+ tumors.

CONCLUSIONS:

These data demonstrated that PDPN expression in the cancer cells is associated with high risk of thrombosis, leading to unfavorable overall survival of the mice. This study provides new insights into the functions of PDPN in cancer-associated thrombosis and in the pathophysiology of OSCC.

• Authors: Hsing-Ying Lee, Ni-Yen Yu, Shiang-Hsuan Lee, Hui-Ju Tsai, Chih-Ching Wu, Ju-Chien Cheng, Ding-Ping Chen, Ying-Ru Wang, Ching-Ping Tseng
• Journal: Biomedical journal (Biomed J) Vol. 43 Issue 2 Pg. 146-162 (04 2020) ISSN: 2320-2890 [Electronic] United States
• PMID: 32441651 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2019 Chang Gung University. Published by Elsevier B.V. All rights reserved.

Chemical References

• Membrane Glycoproteins
• PDPN protein, human

Topics

• Animals
• Carcinoma, Squamous Cell (chemically induced)
• Cell Line, Tumor
• Cell Movement (drug effects, physiology)
• Cell Proliferation (drug effects, physiology)
• Disease Models, Animal
• Heterografts (pathology)
• Humans
• Membrane Glycoproteins (metabolism, pharmacology)
• Mice, Nude
• Mouth Neoplasms (chemically induced, mortality)
• Platelet Aggregation (drug effects)
• Squamous Cell Carcinoma of Head and Neck (chemically induced)
• Thrombosis (chemically induced)